COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 2313: Articles 23121-23130  | Next

nanoDoc: RNA modification detection using Nanopore raw reads with Deep One-Class Classification
Ueda, H.
10.1101/2020.09.13.295089 — Posted: 2020-09-13
Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 disease severity
Inde, Z., Yapp, C., Joshi, G. N., Spetz, J., Fraser, C., Deskin, B., Ghelfi, E., Sodhi, C., Hackam, D., Kobzik, L., Croker, B., Brownfield, D., Jia, H., Sarosiek, K. A.
10.1101/2020.09.13.276923 — Posted: 2020-09-13
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings
Westhaus, S., Widera, M., Rabenau, H., Hoehl, S., Bojkova, D., Cinatl, J., Ciesek, S.
10.1101/2020.09.11.292581 — Posted: 2020-09-13
SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike
Guthmiller, J. J., Stovicek, O., Wang, J., Changrob, S., Li, L., Halfmann, P., Zheng, N.-Y., Utset, H., Stamper, C. T., Dugan, H. L., Miller, W. D., Huang, M., Dai, Y.-N., Nelson, C. A., Hall, P. D., Jansen, M., Shanmugarajah, K., Donington, J. S., Krammer, F., Fremont, D., Joachimiak, A., Kawaoka, Y., Tesic, V., Madariaga, M. L., Wilson, P. C.
10.1101/2020.09.12.294066 — Posted: 2020-09-13 Discussion: Offsite
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease as a Clinical Candidate for the Potential Treatment of COVID-19
Boras, B., Jones, R. M., Anson, B. J., Arenson, D., Aschenbrenner, L., Bakowski, M. A., Beutler, N., Binder, J., Chen, E., Eng, H., Hammond, J., Hoffman, R., Kadar, E. P., Kania, R., Kimoto, E., Kirkpatrick, M. G., Lanyon, L., Lendy, E. K., Lillis, J. R., Luthra, S. A., Ma, C., Noell, S., Obach, R. S., O'Brien, M. N., O'Connor, R., Ogilvie, K., Owen, D., Pettersson, M., Reese, M. R., Rogers, T., Rossulek, M. I., Sathish, J. G., Steppan, C., Ticehurst, M., Updyke, L. W., Zhu, Y., Wang, J., Chatterjee, A. K., Mesecar, A. D., Anderson, A. S., Allerton, C.
10.1101/2020.09.12.293498 — Posted: 2020-09-13
SARS2 simplified scores to estimate risk of hospitalization and death among patients with COVID-19
Dashti, H., Roche, E., Bates, D., Mora, S., Demler, O.
10.1101/2020.09.11.20190520 — Posted: 2020-09-13
Cerebral Venous Sinus Thrombosis Associated with SARS-CoV-2; a Multinational Case Series
Mowla, A., Shakibajahromi, B., Shahjouei, S., Borhani-Haghighi, A., Rahimian, N., Baharvahdat, H., Naderi, S., Khorvash, F., Altafi, D., Ebrahimzadeh, S. A., Farahmand, G., Vaghefi Far, A., Sharma, V. K., Aghayari Sheikh Neshin, S., Tsivgoulis, G., Zand, R.
10.1101/2020.09.12.20186106 — Posted: 2020-09-13
Temporal Analysis of COVID-19 Peak Outbreak
Tewari, A.
10.1101/2020.09.11.20192229 — Posted: 2020-09-13
Clinical effectiveness of drugs in hospitalized patients with COVID-19 infection: a systematic review and meta-analysis.
Abeldano Zuniga, R. A., Coca, S., Abeldano, G., Gonzalez Villoria, R. A. M.
10.1101/2020.09.11.20193011 — Posted: 2020-09-13 Discussion: Offsite
Anakinra and Intravenous IgG versus Tocilizumab in the Treatment of COVID-19 Pneumonia
Zantah, M., Dominguez Castillo, E., Gangemi, A. J., Patel, M., Chowdhury, J., Verga, S., Abramian, O., Zheng, M., Lu, K., Lau, A., Levinson, J., Zhao, H., Criner, G. J., Caricchio, R.
10.1101/2020.09.11.20192401 — Posted: 2020-09-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).